Home Newsfeeds Russian Defense Ministry Reports New Strikes On Ukraine

Russian Defense Ministry Reports New Strikes On Ukraine

-Reuters

byBenzinga Newsdesk

October 19, 2022

1 minute read

-Reuters

electroCore, Inc. Announces Data Highlighting Non-Invasive Vagus Nerve Stimulation For Treatment Of Acute Neurological Injury Presented At 2023 World Stroke Congress

By Benzinga Newsdesk

October 10, 8:03 AM

"VANQUISH" Clinical Trial (n=40) suggests safety and efficacy of nVNS for the Treatment of Headache Associated with Subarachnoid Hemorrhage (SAH) "NOVIS" Clinical Trial (n=150) of nVNS for the acute treatment of

ECOR

What’s Up With Riot Platforms Stock?

By Henry Khederian

June 7, 1:05 PM

Riot Platforms Inc (NASDAQ: RIOT) shares are trading lower by 4.39% to $10.42 Wednesday afternoon. Crypto-related stocks have been volatile this week after the SEC sued Coinbase for operating as an unregistered securities exchange, broker and clearing agency.

RIOT

B of A Securities Downgrades Coupang to Neutral

By Benzinga Newsdesk

March 2, 12:50 PM

B of A Securities analyst Susie Lee downgrades Coupang (NYSE:CPNG) from Buy to Neutral.

CPNG

Atara Biotherapeutics Presents New MRI And Updated Open-Label Extension Data From Phase 1 Study Of ATA188 In Progressive Multiple Sclerosis At ECTRIMS 2022 October 26-28

By Benzinga Newsdesk

October 26, 2:07 AM

Sustained Improvement Observed in ATA188 Treated Patients Achieving Confirmed Disability Improvement (CDI) in Open Label Extension (OLE) with up to 46 Months Follow up Patients Treated with ATA188 that Achieved CDI

ATRA

Russian Defense Ministry Reports New Strikes On Ukraine

Related Posts

electroCore, Inc. Announces Data Highlighting Non-Invasive Vagus Nerve Stimulation For Treatment Of Acute Neurological Injury Presented At 2023 World Stroke Congress

What’s Up With Riot Platforms Stock?

B of A Securities Downgrades Coupang to Neutral

Atara Biotherapeutics Presents New MRI And Updated Open-Label Extension Data From Phase 1 Study Of ATA188 In Progressive Multiple Sclerosis At ECTRIMS 2022 October 26-28